Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2010
10/07/2010WO2010112510A1 Use of flavonoids to increase the bioavailability of hesperetin
10/07/2010WO2010112113A1 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
10/07/2010WO2010111948A1 Arylmethylamine compounds, preparation methods and pharmaceutical uses thereof
10/07/2010WO2010111935A1 New salvianolic acid compound l, preparation method and use thereof
10/07/2010WO2010111753A1 Compositions and methods for treatment of aortic fibrosis
10/07/2010WO2010063470A9 Methods for preventing or reducing colon carcinogenesis
10/07/2010US20100256698 Isoquinolinone Potassium Channel Inhibitors
10/07/2010US20100256240 Prostacyclin derivatives
10/07/2010US20100256237 Potentiating the effect of compound comprising nitric oxide
10/07/2010US20100256229 Compositions of cholinesterase inhibitors
10/07/2010US20100256224 Novel angiogenesis inhibitor
10/07/2010US20100256223 Oligonucleotides for modulating target rna activity
10/07/2010US20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide
10/07/2010US20100256211 Inhibition of Chronic Tissue Transplant Rejection
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256207 Amorphous olmesartan medoxomil
10/07/2010US20100256206 Crystalline form b of olmesartan medoxomil
10/07/2010US20100256196 Biomarkers for Atherosclerosis
10/07/2010US20100256194 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
10/07/2010US20100256193 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
10/07/2010US20100256178 Super-oxide dismutase mimetics
10/07/2010US20100256172 Heteroaryls and uses thereof
10/07/2010US20100256166 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256153 Methods for preventing or reducing risk of mortality
10/07/2010US20100256146 Trisubstituted piperidines
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256129 Selective androgen receptor modulators (sarms) and uses thereof
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100256108 Indazole acrylic acid amide compound
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100256083 Organ protection, preservation and recovery
10/07/2010US20100256075 High Yield Secretion of Multimeric Recombinant Protein
10/07/2010US20100256063 Method for Increasing Cardiac Mass and Performance
10/07/2010US20100256055 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/07/2010US20100256045 Use of Measles Virus Nucleoprotein for Treating Atherosclerosis
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100256042 Methods of using chimeric coiled-coil molecule
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255126 Medicament for treatment of cancer and other diseases
10/07/2010US20100255123 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter
10/07/2010US20100255114 Metabolic imprinting
10/07/2010US20100255110 Functional agricultural product and method for cultivating the same
10/07/2010US20100255105 Extended release pharmaceutical composition comprising metoprolol succinate
10/07/2010US20100255088 Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease
10/07/2010US20100255086 Method for oral mucosal absorption of acetyl salycylic acid
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255067 Controlled Release Pharmaceutical Compositions of Pregabalin
10/07/2010US20100255066 Orally-administered agent
10/07/2010US20100255063 Compressed Chewing Gum Tablet
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255055 Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same
10/07/2010US20100255054 Pharmaceutical composition for treatment and prevention of restenosis
10/07/2010US20100255051 Polyketal polymers, and methods of making and using same
10/07/2010US20100255041 Remedy for the treatment of cardio-vascular diseases or disorders
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254966 Treatment of glycogen storage disease type ii
10/07/2010US20100254953 Cell growth method and pharmaceutical preparation for tissue repair and regeneration
10/07/2010US20100254952 Isolated myeloid-like cell populations and methods of treatment therewith
10/07/2010US20100254941 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
10/07/2010DE102009016553A1 Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung Sulfonamide and sulfoximine-substituted Diaryldihydropyrimidinone and their use
10/07/2010CA2757726A1 Acrylamide compounds and the use thereof
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757396A1 Medical composition for treatment or prophylaxis of eye diseases
10/07/2010CA2757222A1 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
10/07/2010CA2757190A1 Production method for ubiquinone powder for use in preparations and product thereof
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2757106A1 5-ht receptor modulating compounds
10/07/2010CA2757076A1 Compositions and methods for treatment of aortic fibrosis
10/07/2010CA2756823A1 New compound of salvianolic acid l, preparation method and use thereof
10/06/2010EP2236153A2 Compositons and methods for treating cardiac conditions
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236140A1 Regulation of phospholipase D activity
10/06/2010EP2236131A2 Compositions for manipulating the lifespan and stress response of cells and organisms
10/06/2010EP2236106A1 Apparatus for stenting adapted for use in a bifurcated vessel comprising enhanced protection against embolism, restenosis and thrombus formation
10/06/2010EP2235032A2 Chemical-catalytic method for the peracylation of oleuropein and its products of hydrolysis
10/06/2010EP2235011A1 Substituted pyrrolo[2, 3-b]and pyrazolo[3, 4-b]pyridines for use as adenosine receptor ligands
10/06/2010EP2234983A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP2234980A1 Fused cynopryridines and the use thereof
10/06/2010EP2234966A2 Azetidine derivatives, their preparation and their application in therapy
10/06/2010EP2234631A1 Compounds and methods for the treatment of vascular disease
10/06/2010EP2234615A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP2234614A2 Pharmaceutical composition
10/06/2010EP2234609A1 Treatment of heart disease using -blockers
10/06/2010EP2234603A1 Room temperature stable, lyophilized natriuretic peptide formulations
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 1595